B · Normal
On September 22, the concept of innovative drugs in Hong Kong stocks strengthened. CanSino Biologics rose by more than 10%, Jingtai Holdings rose by more than 4%, and WuXi AppTec, Innovent Biologics, etc. followed suit.
Comments